Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

BACKGROUND: The efficacy and safety of nivolumab versus chemotherapy was evaluated in the Japanese subpopulation from the overall intent-to-treat (ITT) population of the ATTRACTION-3 trial conducted in patients with advanced esophageal squamous cell carcinoma (ESCC) as second-line treatment. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masanobu, Kato, Ken, Okada, Morihito, Chin, Keisho, Kadowaki, Shigenori, Hamamoto, Yasuo, Doki, Yuichiro, Kubota, Yutaro, Kawakami, Hisato, Ogata, Takashi, Hara, Hiroki, Muto, Manabu, Nakashima, Yuichiro, Ishihara, Ryu, Tsuda, Masahiro, Motoyama, Satoru, Kodani, Mamoru, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794205/
https://www.ncbi.nlm.nih.gov/pubmed/33170461
http://dx.doi.org/10.1007/s10388-020-00794-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794205/
https://www.ncbi.nlm.nih.gov/pubmed/33170461
http://dx.doi.org/10.1007/s10388-020-00794-x

Ejemplares similares